Reaction
Urine Ketone Body Present reporting signals
As of the last recalculation, Urine Ketone Body Present appears in 1,560 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 123.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 93 | 123.8 | 124.8 |
| Alemtuzumab | 157 | 120.3 | 121.3 |
| Cimetidine | 43 | 61.2 | 61.5 |
| Dapagliflozin | 114 | 52.1 | 52.3 |
| Empagliflozin | 167 | 36.9 | 37.0 |
| Canagliflozin | 77 | 36.1 | 36.2 |
| Tranexamic Acid | 11 | 16.6 | 16.6 |
| Insulin Glulisine | 12 | 15.9 | 15.9 |
| Pitavastatin Calcium | 12 | 15.8 | 15.8 |
| Methylprednisolone | 141 | 14.9 | 14.9 |
| Metformin Hydrochloride Tablets | 43 | 10.3 | 10.3 |
| Metformin Hydrochloride Extended-Release Tablets | 43 | 10.3 | 10.3 |
| Metformin Hydrochloride Tablet | 43 | 10.3 | 10.3 |
| Sitagliptin And Metformin Hydrochloride | 16 | 10.0 | 10.0 |
| Metformin Hydrochloride | 43 | 9.9 | 9.9 |
| Insulin Aspart | 47 | 9.8 | 9.8 |
| Insulin Glargine-Yfgn | 15 | 9.2 | 9.2 |
| Insulin Lispro | 90 | 9.2 | 9.2 |
| Sitagliptin | 45 | 8.5 | 8.6 |
| Linagliptin | 10 | 7.4 | 7.4 |
| Insulin Degludec | 12 | 6.9 | 6.9 |
| Tafamidis | 6 | 6.8 | 6.8 |
| Ranitidine | 85 | 6.0 | 6.0 |
| Liraglutide | 20 | 5.5 | 5.5 |
| Asfotase Alfa | 4 | 5.3 | 5.3 |
| Alpelisib | 3 | 4.6 | 4.6 |
| Dalfampridine | 23 | 4.3 | 4.3 |
| Dulaglutide | 23 | 3.5 | 3.5 |